0001629697-15-000002.txt : 20150106 0001629697-15-000002.hdr.sgml : 20150106 20150106133146 ACCESSION NUMBER: 0001629697-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20150106 DATE AS OF CHANGE: 20150106 EFFECTIVENESS DATE: 20150106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pleasanton Pharma Ventures I, L.P. CENTRAL INDEX KEY: 0001629697 IRS NUMBER: 472181198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-231504 FILM NUMBER: 15509150 BUSINESS ADDRESS: STREET 1: 5000 HOPYARD ROAD, SUITE 330 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: 925-201-1083 MAIL ADDRESS: STREET 1: 5000 HOPYARD ROAD, SUITE 330 CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: Pleasanton Pharma Ventures I, LLC DATE OF NAME CHANGE: 20150105 D 1 primary_doc.xml X0707 D LIVE 0001629697 Pleasanton Pharma Ventures I, L.P. 5000 HOPYARD ROAD, SUITE 330 PLEASANTON CA CALIFORNIA 94588 925-201-1083 DELAWARE Pleasanton Pharma Ventures I, LLC Limited Partnership true 2014 Jorge Puente 5000 Hopyard Road, Suite 330 Pleasanton CA CALIFORNIA 94588 Executive Officer Director Managing Member of the General Partner of the Issuer Bruce Bouchard 5000 Hopyard Road, Suite 330 Pleasanton CA CALIFORNIA 94588 Executive Officer Director Managing Member of the General Partner of the Issuer David Lilley 5000 Hopyard Road, Suite 330 Pleasanton CA CALIFORNIA 94588 Executive Officer Director Managing Member of the General Partner of the Issuer Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b 3C 3C.1 false 2014-12-23 true true true false 100000 Harpeth Securities, LLC 109821 None None One American Center 3100 West End Avenue, Suite 710 Nashville TN TENNESSEE 37203 CA CALIFORNIA CO COLORADO CT CONNECTICUT GA GEORGIA IL ILLINOIS MA MASSACHUSETTS NY NEW YORK OH OHIO TN TENNESSEE false 200000000 12800000 187200000 false 12 0 3500000 true 0 true None of the offering proceeds will be paid directly to any executive officer, director or promoter. The Issuer pays a management fee which, directly or indirectly, may be paid to executive officers, directors and promoters. false Pleasanton Pharma Ventures I, L.P. /s/ Bruce Bouchard Bruce Bouchard Managing Member of the General Partner 2015-01-02